OR30-01 Real-World Minimed™ 670G System Use and Glycemic Outcomes of Pediatric and Adult Individuals Living with Type 1 Diabetes (T1D) in the United States

Introduction: The MiniMed™ 670G system was FDA-approved in 2016 for adults and adolescents ≥14yrs, and in 2018 for children ages 7-13yrs with T1D. Since then, use of the system has grown to over 180,000 people in the U.S. The glycemic control benefits of real-world MiniMed™ 670G system Auto Mode use...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigersky, Robert Alan, Stone, Michael, Agrawal, Pratik, Zhong, Alex, Velado, Kevin, Cordero, Toni, Shin, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207810/
http://dx.doi.org/10.1210/jendso/bvaa046.1708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207810/
http://dx.doi.org/10.1210/jendso/bvaa046.1708

Ejemplares similares